Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Government authorities secure mobile communication with crypto solutions from Sectra

Linköping – May 7, 2020 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) is receiving new orders for its crypto solutions for mobile telephony, smartphones and the blue-light operations’ communication network TETRA from several European government authorities. Order bookings for Sectra’s Secure Communications operating area amounted to approximately SEK 35 million in April 2020. With solutions from Sectra, authorities that handle sensitive information are able to maintain their operations even when faced with exceptional circumstances.“

Interim Report First Quarter 2020

STENOCARE A/S (“STENOCARE”) today announces its results for the period 01.01.2020 – 31.03.2020. The report is available on www.stenocare.com/investor-relations.Thomas Skovlund Schnegelsberg, CEO of STENOCARE, comments: “Financially, the Q1-20 result was expected because of our pause in sales of products. We run a lean and agile operation that has been adapted to handle the current situation. In February, STENOCARE was honoured to be identified as a European leader in medical cannabis and a company to watch by the leading medical cannabis analyst’ Prohibition Partners. Adding to this

Bioservo Technologies AB Interim Report January - March 2020

First quarter in figures · Net sales of SEK 3.0 M (1.7) · EBITDA of SEK -6.6 M (-4.4) · EBIT of SEK -7.5 M (-5.4) · Earnings for the period amounted to SEK -7.5 M (-5.4) · Earnings per share before and after dilution amounted to SEK -0.53 (-0.60) · Cash flow from operating activities for the period amounted to SEK -6.2 M (-8.3) · At 31 March, cash and cash equivalents were SEK 50.3 M (17.3) Significant events during the period Launch of a new version of Ironhand®, the latest active soft exoskeleton from Bioservo Technologies that further optimizes the user

Zwipe Q1 2020 operational update

OSLO, NORWAY – 7 MAY 2020 – Q1 2020 Highlights · Zwipe has significantly expanded its efforts towards smart card manufacturers in the last quarter. Zwipe is now in direct dialogue or conducting projects with over 40 of the world’s top 50 smart card manufacturers (SCMs), out of which 8 are among world’s top 10. This is an increase from 29 during March alone · Zwipe announced that Masria Digital Payments (MDP), one of the largest smart card manufacturers in the Middle East and Africa, has selected Zwipe to support its drive to roll out biometric payment solutions · Zwipe listed

Isofol’s Board of Directors resolve on a fully guaranteed preferential rights issue of approximately SEK 150 million

GOTHENBURG, Sweden, May 7, 2020 - Isofol Medical AB’s (publ) (Nasdaq First North Premier Growth Market: ISOFOL) (“Isofol” or the “Company”) Board of Directors have today, pursuant to the authorization granted by the extra general meeting on May 5, 2020, resolved on a fully guaranteed new share issue of a maximum of 42,739,736 shares with preferential rights for the Company’s existing shareholders (the “Rights Issue”). The subscription price in the Rights Issue is SEK 3.5 per share. Through the Rights Issue, the Company will receive approximately SEK 150 million before transaction costs

National Institute on Aging and PHI sign collaboration agreement

The National Institute on Aging  (NIA) and Phase Holographic Imaging (PHI) recently entered a collaboration agreement, aiming to develop an add-on fluorescent module for PHI’s HoloMonitor imaging cytometer. NIA is one of the 27 research institutes of the National Institutes of Health, leading a broad scientific effort to under­stand the nature of aging and thereby extend our healthy, active years of life. National Institutes of Health  is an agency of the United States Department of Health & Human Services.In pursuit of making novel

Konecranes wins Fennia Prize 20 award for its innovative S- and C-series lifting products

Konecranes’ benchmark-setting S-series  cranes and C-series  hoists have been recognized by Design Forum Finland, winning the 2020 Fennia IPR Excellence prize for the protection of intellectual property rights and with the S-series earning honorable mention for the top design award."Besides bringing game-changing technological innovations to the customers, Konecranes is investing extensively in the design quality and user experience of its products. The S-series crane in particular is a milestone

Penneo A/S has applied for admission to trading on Nasdaq First North Growth Market Denmark

MUST NOT BE PUBLISHED, DISTRIBUTED, OR SUPPLIED OR PARTICULAR, DIRECTLY OR INDIRECTLY, IN OR TO US, AUSTRALIA, CANADA OR JAPAN.This notice does not constitute a tender document. No person should buy or subscribe for shares in Penneo A/S ("Penneo" or "the Company"), unless this is done on the basis of information in the company description published by the Company in connection with the offering of shares for trading on Nasdaq First North Growth Market Denmark. The company description is available on the Company's website.  Company Announcement No. 1-2020 Copenhagen, May 7th, 2020

Ulf Bonnevier, CFO and Vice President, leaves his position at Humana

Ulf Bonnevier, CFO since 2012 and Vice President since 2016, will be leaving his position at Humana. He has played a key role in the development of Humana into the leading Nordic care group that the company represents today. He was also crucial in Humana’s listing at Nasdaq Stockholm in 2016."During his time at Humana, Ulf Bonnevier has successfully contributed to the development of Humana. Ulf and I have worked closely together for over six years. He is an incredibly valued colleague, not only by me as CEO but also by the board, others in management and the organisation. His leadership and

Q1 report January - March 2020

Strong collections and strategic investment in challenging marketHighlights first quarter 2020 · Net collections amounted to EUR 19.3M (18.1)* · Cash EBITDA amounted to EUR 16.9M (16.4)* · Unrealized FX losses of EUR 2.1M driven by unfavorable movements of Croatian Kuna and Hungarian Forint on the back of COVID-19 · Net profit for the period of EUR 0.5M (loss of 0.5)* · Strategic investment acquired 9.9% stake in Addiko Bank AG, totaling approximately EUR 30M, and exercised a call option to acquire a further 10.1% that is subject to regulatory approval · Buy-out of

AFRY builds production line for Oatly in Singapore

The oat drink manufacturer Oatly takes the next step in its global expansion and starts production in Singapore. AFRY has won an order for a turn-key project to build the production line for oat base, where the technology is a development of previous common projects between AFRY and Oatly.Since earlier, Oatly and AFRY have a close collaboration that covers Oatly’s production facilities in Sweden, USA and the Netherlands. As part of the establishment on the Asian market, Oatly starts its own production in Singapore, where AFRY is responsible for project management, process design, mechanical

Electrolux Q1 interim report 2020: Proactive cost actions and strengthened liquidity

The comments and figures in this report refer to continuing operations unless otherwise stated Highlights of the first quarter of 2020 · Net sales declined to SEK 26,578m (27,408). Sales growth was -5.1%, due to lower volumes. The development of the coronavirus pandemic impacted market demand at the end of the quarter.   · Operating income amounted to SEK 122m (-53), corresponding to a margin of 0.5% (-0.2). The comparison period included non-recurring items of SEK -1,054m. · The negative impact on operating income from the coronavirus situation was approximately SEK 400m.

Invitation to the presentation of Bactiguard’s interim report on May 13, 2020

Bactiguard Holding AB (publ) publishes the interim report for the first quarter on Wednesday May 13, 2020 at 8:00 CET.In connection with this, a webcast for investors, analysts and media will be held at 10:00 CET on May 13. CEO Cecilia Edström and acting CFO Lina Arverud will present the interim report and answer questions. The report and a presentation for the webcast will be available at Bactiguard’s website www.bactiguard.com. To participate in the webcast, please use this link:https://event.on24.com/wcc/r/2266251/5AF82FEF4183590B19A6D30FC570901F Questions may be submitted by

BIMobject: Interim Report January – March 2020

Financial summary · Net sales of MSEK 35.8 (32.7), +10%.  · Platform* net sales (recurring revenue) amounted to MSEK 23.8 (21.5), +10%.  · Invoiced sales of MSEK 28.6 (29.6), -3%.  · Platform* invoiced sales amounted to MSEK 20.6 (16.8), +22%.  · EBITDA of MSEK -23.3 (-28.3), corresponding to an EBITDA margin of -65% (-86%).  · Basic earnings per share amounted to SEK -0.22 (-0.23).  · Group cash flow** from operating activities MSEK -13.6 (-24.6).  · The accumulated number of users in thousands increased by 32 percent to approximately 1,879 (1,429).

Q1 report January - March 2020

Strong collections and strategic investment in challenging marketHighlights first quarter 2020 · Net collections amounted to EUR 19.5M (18.9)* · Cash EBITDA amounted to EUR 17.2M (16.8)* · Unrealized FX losses of EUR 2.4M driven by unfavorable movements of Croatian Kuna and Hungarian Forint on the back of COVID-19 · Net loss for the period of EUR 0.1M (profit of 0.0)* · Gross ERC at the end of March 2020 was EUR 308M (328 at December 2019) · Strategic investment acquired 9.9% stake in Addiko Bank AG, totaling approximately EUR 30M, and exercised a call option to acquire

Proact wins contract for modernising the Fortnox cloud platform

Proact has signed a contract with Fortnox to design and deliver a new technology foundation for the Fortnox cloud-based platform, which serves more than 300,000 customers. Total contract value for this multi-year agreement is estimated at SEK 30 million.Fortnox, listed at NGM Nordic SME, is the market leader in Sweden with its cloud-based Fintech services platform, currently used by more than 300,000 small businesses and accounting agencies. By introducing Software-as-a-Service, Fortnox has successfully applied innovation to transform its industry, freeing customers from investing in

KONE DX Class elevators win four prestigious Red Dot Design Awards

KONE Corporation, press release, May 7, 2020  KONE Corporation, a global leader in the elevator and escalator industry, has won four awards for its KONE DX Class elevators in the renowned Red Dot Award: Product Design 2020 competition. The KONE DX Class elevator interior collection and the KONE DX Class digital experience elevator concept were awarded for their outstanding design features, innovativeness and smart elements.Launched in 2019, the KONE DX Class is the world's first digital elevator series. With built-in connectivity as standard, it brings a new user experience to

Humana reports first quarter 2020 results

A quarter marked by mobilisation, unity and heroic effortsHumana’s main focus during the first quarter, and mainly during its second half, was, like the rest of our society, focused on preparing for and managing the new coronavirus. Humana serves 9,000 customers and clients, and all operations must preventing spread and handling any cases of covid-19. Financially, the development was good. Humana’s revenue increased by 13 percent, including 4 percent organically, and the operating profit increased despite the negative effects connected to the pandemic in the second half of the quarter.

Outotec’s interim report January-March 2020

OUTOTEC OYJ INTERIM REPORT MAY 7, 2020 AT 9:00 AM   Outotec’s interim report January-March 2020  Growth in sales and adjusted EBIT, uncertain operating environment affected order intake “COVID-19 caused rapid uncertainty impacting the global operating environment and prompting travel restrictions, sourcing challenges and limiting access to customer sites.   Order intake decreased by 28% compared to the comparison period because customers started to slow down decision-making relating to large projects. In the Minerals Processing segment, smaller equipment orders continued to be

BioGaia Interim Management Statement 1 January – 31 March 2020

Increased product sales resulted in a good start of the year Net sales amounted to SEK 182.8 million (171.3), an increase of 7% (excluding foreign exchange effects, 4%). Product sales, net sales excluding royalty revenues, amounted to SEK 177.0 million (164.5), an increase of 8% (excluding foreign exchange effects, 5%). Net sales in the Paediatrics segment reached SEK 142.5 million (133.6), an increase of 7%. Product sales within Paediatrics amounted to SEK 139.3 million (128.1), an increase of 9%. Net sales in the Adult Health segment amounted to SEK 40.2 million (37.6), an

Tradedoubler Interim Report January - March 2020

The first quarter January – March 2020 · Net sales amounted to SEK 305 M (306) a decrease of -1% or -3% adjusted for changes in exchange rates compared to the same period last year. · Gross profit adjusted for change related items was SEK 63 M (66), a decrease of -4% or -6% adjusted for changes in exchange rates. Gross margin adjusted for change related items was 20.7% (21.5). · Operating costs excluding depreciation and change related items were SEK 49M (53), a decrease of -7%. · EBITDA amounted to SEK 14 M (13). Adjusted for change related items, EBITDA was SEK 14 M (13).

InDex Pharmaceuticals Holding AB (publ) interim report January – March 2020

FDA and EMA endorse the advancement of cobitolimod into phase III studies“The positive responses from the regulators is an important external validation of our study results and cobitolimod’s potential,” says Peter Zerhouni, CEO of InDex Pharmaceuticals. Period January – March 2020 · Net sales amounted to SEK 0.0 (0.0) million · Operating loss amounted to SEK –24.0 (–17.2) million · Result after tax amounted to SEK –24.0 (–17.2) million, corresponding to SEK –0.27 per share (–0.25) before and after dilution · Cash flow from operating activities amounted to SEK –21.9 (–18.4)

Interim report first quarter 2020

Irisity AB (publ) delivers strong first quarter with growth and increased profitability.CEO comments on first quarter: Net sales during the period amounted to MSEK 9.8 (8.4), the work performed for own account to MSEK 3.1 (4.5). EBITDA amounted to MSEK -0.8 (-1.5) and the profit after tax was MSEK -4.2 (-4.5). Gross margin was 64.3 percent (60.3). Cash position MSEK 34.6. Despite the general uncertainty and impact from measures put in place by authorities around the world to reduce the spread of COVID-19, we deliver a strong quarter. In terms of net sales, the quarter is a new record.

NCC to construct Manglerud Swim Center in Oslo

NCC Building has commenced the construction of Manglerud Swim and Activity Center on behalf of Undervisningsbygg KF. On May 6 this year, the Oslo City Council approved the commencement of the construction. The order value is approximately NOK 385 million. Illustration: Asplan Viak   “We are looking forward to commencing construction of this facility, which in addition to three swimming pools will provide space for a number of leisure activities. Together with the developer and its advisers, we have developed a project that I am certain will be greatly appreciated by the residents

Read original
There are no items matching the current filter
There are no more items matching the current filter
Back to top